Autobio Diagnostics Co Ltd
SSE:603658
Autobio Diagnostics Co Ltd
Cash from Investing Activities
Autobio Diagnostics Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cash from Investing Activities
-¥822.5m
|
CAGR 3-Years
35%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cash from Investing Activities
-¥1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Cash from Investing Activities
-¥1.9B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-38%
|
Winner Medical Co Ltd
SZSE:300888
|
Cash from Investing Activities
¥1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cash from Investing Activities
-¥290.7m
|
CAGR 3-Years
51%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Cash from Investing Activities
-¥3.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
See Also
What is Autobio Diagnostics Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-822.5m
CNY
Based on the financial report for Mar 31, 2024, Autobio Diagnostics Co Ltd's Cash from Investing Activities amounts to -822.5m CNY.
What is Autobio Diagnostics Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-17%
Over the last year, the Cash from Investing Activities growth was 38%. The average annual Cash from Investing Activities growth rates for Autobio Diagnostics Co Ltd have been 35% over the past three years , -17% over the past five years .